<\/p>\n
NEW FILINGS<\/strong><\/p>\n Company: Adaptive Biotechnologies Corporation Company: Morphic Holding, Inc. Company: Genmab A\/S Company: Linx S.A. Company: Cambium Networks, Inc Company: Akero Therapeutics Company: Prevail Therapeutics Inc. Company: Dermavant Sciences, Inc. Company: BridgeBio Pharma, Inc. Company: Atreca Inc TERMS ADDED<\/strong><\/p>\n Company: CrowdStrike Holdings Inc. Company: Revolve Group, Inc Company: GSX Techedu Inc. Company: Mohawk Group Holdings
\nSymbol: ADPT
\nDescription: They are advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs & Co., J.P. Morgan, BofA Merrill Lynch
\nCo-Manager(s): Cowen, Guggenheim, William Blair, BTIG
\nFiled: 5-30-19
\nListed Cash Raise: $230m<\/p>\n
\nSymbol: MORF
\nDescription: They are a biopharmaceutical company applying our proprietary insights into integrins to discover and develop a pipeline of potentially first-in-class oral small-molecule integrin therapeutics.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, Cowen, BMO Capital Markets, Wells Fargo Securities
\nFiled: 5-30-19
\nListed Cash Raise: $86.25m<\/p>\n
\nSymbol: GMAB
\nDescription: They are an international biotechnology company specializing in antibody therapeutics for the treatment of cancer and other diseases.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): BofA Merrill Lynch, Morgan Stanley, Jefferies
\nCo-Manager(s): Guggenheim Securities, RBC Capital
\nFiled: 5-28-19
\nListed Cash Raise: $500m<\/p>\n
\nSymbol: LINX
\nDescription: They are a leading cloud-based technology company in Latin America and a market leader in Brazil in terms of revenue.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, JP Morgan, Jefferies, BofA Merrill Lynch, Itau BBA
\nFiled: 5-29-19
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: CMBM
\nDescription: They provide wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises and government agencies.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, Goldman Sachs
\nCo-Manager(s): Deutsche Bank, Raymond James, JMP Securities, Oppenheimer
\nFiled: 5-29-19
\nListed Cash Raise: $75m<\/p>\n
\nSymbol: AKRO
\nDescription: They are a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical need.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, Jefferies, Evercore ISI
\nCo-Manager(s): Roth Capital
\nFiled: 5-24-19
\nListed Cash Raise: $86.25m<\/p>\n
\nSymbol: PRVL
\nDescription: They are a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with devastating neurodegenerative diseases.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, BofA Merrill Lynch, Cowen
\nCo-Manager(s): Wedbush PacGrow
\nFiled: 5-24-19
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: DRMT
\nDescription: They are a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in medical dermatology.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, SVB Leerink, Guggenheim Securities
\nFiled: 5-24-19
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: BBIO
\nDescription: They are a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): J.P. Morgan, Goldman Sachs & Co, Jefferies, SVB Leerink, KKR
\nCo-Manager(s): Piper Jaffray, Mizuho Securities, BMO Capital Markets, Raymond James
\nFiled: 5-24-19
\nListed Cash Raise: $225m<\/p>\n
\nSymbol: BCEL
\nDescription: They are a biopharmaceutical company utilizing our differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Cowen, Evercore ISI, Stifel
\nCo-Manager(s): Canaccord Genuity, Brookline Capital
\nFiled: 5-24-19
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: CRWD
\nDescription: They believe they are defining a new category called the Security Cloud, with the power to transform the security industry much the same way the cloud has transformed the CRM, HR, and service management industries.
\nShares: 18 million
\nPrice Range: $19.00-$23.00
\nTrade Date: Wednesday, 6\/12
\nUnderwriter(s): Goldman Sachs, JP Morgan, BofA Merrill Lynch, Barclays
\nCo-Manager(s): Credit Suisse, Jefferies, RBC Capital, Stifel, HSBC, Macquarie Capital, Piper Jaffray, SunTrust Robinson Humphrey, BTIG, JMP Securities, Mizuho Securities, Needham & Co., Oppenheimer & Co.
\nTerms Added: 5-28-19<\/p>\n
\nSymbol: RVLV
\nDescription: REVOLVE is the next-generation fashion retailer for millennial consumers.
\nShares: 11.8 million
\nPrice Range: $16.00-$18.00
\nTrade Date: Friday, 6\/7
\nUnderwriter(s): Morgan Stanley, Credit Suisse, BofA Merrill Lynch, Barclays, Jefferies
\nCo-Manager(s): Cowen, Guggenheim Securities, Raymond James, William Blair
\nTerms Added: 5-27-19<\/p>\n
\nSymbol: GSX
\nDescription: They are a technology-driven education company.
\nShares: 19.8 million
\nPrice Range: $9.50-$11.50
\nTrade Date: Thursday, 6\/6
\nUnderwriter(s): Credit Suisse, Deutsche Bank
\nCo-Manager(s): Barclays, CLSA
\nTerms Added: 5-24-19<\/p>\n
\nSymbol: MWK
\nDescription: Mohawk is a rapidly growing technology-enabled consumer products company.
\nShares: 3.33 million
\nPrice Range: $14.00-$16.00
\nTrade Date: Week of 6\/10
\nUnderwriter(s): Roth Capital, AGP
\nCo-Manager(s): National Securities
\nTerms Added: 5-24-19<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1536],"tags":[],"class_list":["post-8439","post","type-post","status-publish","format-standard","hentry","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/8439","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=8439"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/8439\/revisions"}],"predecessor-version":[{"id":8440,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/8439\/revisions\/8440"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=8439"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=8439"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=8439"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}